Clinical trials data
Continuous Performance Test in depression and bipolar disorder trials: 73 registered studies
Every registered depression and bipolar disorder study on ClinicalTrials.gov that names the Continuous Performance Test in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered depression and bipolar disorder studies name it in an outcome measure
- 73
- Name it in a primary outcome, 37%
- 27 of 73
Tests named in the same studies
- 1
Trail Making Test21 studies, 6 as a primary outcome
- 2
AX Continuous Performance Test21 studies, 4 as a primary outcome
- 3
Digit Span Test20 studies, 5 as a primary outcome
- 4
Symbol Coding16 studies, 4 as a primary outcome
- 5
Verbal Learning15 studies, 9 as a primary outcome
- 6
Card Sorting Test (Berg)14 studies, 6 as a primary outcome
- 7
Stroop Color-Word Test11 studies, 3 as a primary outcome
- 8
Verbal Fluency10 studies, 5 as a primary outcome
- 9
Category Fluency7 studies, 3 as a primary outcome
- 10
N-Back Task7 studies, 3 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 0 | 0 |
| 2010 | 2 | 1 |
| 2011 | 2 | 2 |
| 2012 | 1 | 0 |
| 2013 | 1 | 1 |
| 2014 | 2 | 0 |
| 2015 | 4 | 3 |
| 2016 | 3 | 2 |
| 2017 | 5 | 2 |
| 2018 | 6 | 1 |
| 2019 | 5 | 2 |
| 2020 | 3 | 1 |
| 2021 | 5 | 4 |
| 2022 | 5 | 0 |
| 2023 | 12 | 2 |
| 2024 | 6 | 1 |
| 2025 | 5 | 1 |
| 2026 | 2 | 1 |
Phases and study sizes
By phase
- Early phase 12 studies, 1 as a primary outcome
- Phase 11 studies, 0 as a primary outcome
- Phase 211 studies, 3 as a primary outcome
- Phase 2/31 studies, 0 as a primary outcome
- Phase 32 studies, 1 as a primary outcome
- Phase 45 studies, 5 as a primary outcome
- Not applicable44 studies, 15 as a primary outcome
- Observational7 studies, 2 as a primary outcome
Participants per study
- Phase 290 median, 40 to 110
- Not applicable72 median, 44 to 109
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Phase 2 | 11 | 90 | 40 to 110 |
| Not applicable | 44 | 72 | 44 to 109 |
When depression and bipolar disorder trials measure it
Latest time point of each outcome
- Within a day11 outcomes, 6 as a primary outcome
- Up to 4 weeks20 outcomes, 1 as a primary outcome
- 1 to 3 months19 outcomes, 14 as a primary outcome
- 3 to 6 months13 outcomes, 4 as a primary outcome
- 6 to 12 months2 outcomes, 0 as a primary outcome
- Over 2 years3 outcomes, 0 as a primary outcome
- No duration given3 outcomes, 2 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
68 of the 71 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting13 studies, 3 as a primary outcome
- Not yet recruiting3 studies, 2 as a primary outcome
- Active, not recruiting4 studies, 1 as a primary outcome
- Completed25 studies, 16 as a primary outcome
- Stopped early8 studies, 2 as a primary outcome
- Status unknown20 studies, 3 as a primary outcome
What they test
- Behavioral14 studies, 4 as a primary outcome
- Drug20 studies, 10 as a primary outcome
- Device27 studies, 8 as a primary outcome
- Dietary supplement2 studies, 1 as a primary outcome
- Procedure1 studies, 1 as a primary outcome
- Biological1 studies, 0 as a primary outcome
- Combination product2 studies, 0 as a primary outcome
- Genetic1 studies, 1 as a primary outcome
- Other8 studies, 5 as a primary outcome
- None given5 studies, 1 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States32 studies, 17 as a primary outcome
- China11 studies, 0 as a primary outcome
- Taiwan10 studies, 4 as a primary outcome
- France4 studies, 2 as a primary outcome
- Canada3 studies, 2 as a primary outcome
- Norway2 studies, 0 as a primary outcome
- Spain2 studies, 0 as a primary outcome
- Argentina1 studies, 1 as a primary outcome
- Belgium1 studies, 0 as a primary outcome
- South Korea1 studies, 1 as a primary outcome
- Sweden1 studies, 0 as a primary outcome
- United Kingdom1 studies, 0 as a primary outcome
12 countries in all. A study with sites in several counts in each; 4 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed depression and bipolar disorder studies that name the Continuous Performance Test: 15 of 25, 60%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed depression and bipolar disorder studies that name the Continuous Performance Test | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 6, 24% | 776, 10% |
| Results on ClinicalTrials.gov only | 5, 20% | 1,139, 14% |
| A results paper only | 4, 16% | 1,711, 22% |
| Neither | 10, 40% | 4,327, 54% |
The 73 studies
73 studies match. 27 name the Continuous Performance Test in a primary outcome. Median size 72 participants. Median time to the primary outcome: 8 weeks.
Loading 73 studies; the filters turn on when they arrive.
2026 is partly planned starts. Not shown: 1 that started before 2000 and 1 planned to start after 2026.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 1 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 0 | 0 |
| 2010 | 2 | 1 |
| 2011 | 2 | 2 |
| 2012 | 1 | 0 |
| 2013 | 1 | 1 |
| 2014 | 2 | 0 |
| 2015 | 4 | 3 |
| 2016 | 3 | 2 |
| 2017 | 5 | 2 |
| 2018 | 6 | 1 |
| 2019 | 5 | 2 |
| 2020 | 3 | 1 |
| 2021 | 5 | 4 |
| 2022 | 5 | 0 |
| 2023 | 12 | 2 |
| 2024 | 6 | 1 |
| 2025 | 5 | 1 |
| 2026 | 2 | 1 |
Library tests named most
Conditions
Phases
Participants
Lead sponsor: industry 2, other 71. Interventional 66, observational 7.
As a primary outcomeSecondary or other outcomeThe Continuous Performance Test
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07845409 | Start2027 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants138 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07834203 | Start2025 | PhaseObservational | ConditionsSchizophrenia and psychosis, Depression and bipolar disorder | Participants500 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07512284 | Start2026 | PhasePhase 2 | ConditionsDepression and bipolar disorder | Participants120 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07309302 | Start2025 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Anxiety, PTSD and OCD | Participants64 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07039903 | Start2025 | PhaseNot applicable | ConditionsDepression and bipolar disorder, ADHD | Participants68 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06913309 | Start2025 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants168 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06854224 | Start2025 | PhasePhase 2 | ConditionsDepression and bipolar disorder | Participants30 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06723743 | Start2026 | PhaseNot applicable | ConditionsBrain injury and concussion, Depression and bipolar disorder, Anxiety, PTSD and OCD | Participants30 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT06399406 | Start2024 | PhasePhase 2 | ConditionsDepression and bipolar disorder | Participants70 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT06350396 | Start2024 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants270 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06266611 | Start2024 | PhasePhase 2 | ConditionsDepression and bipolar disorder, Sleep and sleep disorders, Anxiety, PTSD and OCD, Pain and fatigue | Participants185 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06255561 | Start2024 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants75 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06166082 | Start2023 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants130 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06112652 | Start2023 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants100 | Lead sponsorOther | StatusStopped early | Library tests named
|
| NCT06095778 | Start2023 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants100 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06049888 | Start2024 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Anxiety, PTSD and OCD | Participants500 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT05977023 | Start2023 | PhasePhase 2 | ConditionsDepression and bipolar disorder | Participants90 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT05976022 | Start2023 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants50 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05976009 | Start2023 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants80 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05964036 | Start2023 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants45 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05964023 | Start2023 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants150 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05948839 | Start2023 | PhaseNot applicable | ConditionsDepression and bipolar disorder | Participants170 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05884112 | Start2023 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Sleep and sleep disorders | Participants105 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05852912 | Start2023 | PhaseObservational | ConditionsDepression and bipolar disorder | Participants240 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05802004 | Start2024 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Anxiety, PTSD and OCD | Participants40 | Lead sponsorOther | StatusRecruiting | Library tests named
|
Questions, answered from the data
How many depression and bipolar disorder trials use the Continuous Performance Test?
73 registered depression and bipolar disorder studies on ClinicalTrials.gov name it in an outcome measure, 27 of them in a primary outcome: 6% of the condition's 1,247 studies with a cognitive outcome, against 4% of all of them. It is the 9th most named test in depression and bipolar disorder trials.
Which tests do depression and bipolar disorder trials use with the Continuous Performance Test?
The Trail Making Test (21 studies), the AX Continuous Performance Test (21 studies) and the Digit Span Test (20 studies).
How many participants do phase 2 depression and bipolar disorder trials that use the Continuous Performance Test enroll?
Half of the phase 2 studies that name it enroll 90 participants or fewer, and the middle half enroll 40 to 110. 11 of them give a size.
When do depression and bipolar disorder trials measure the Continuous Performance Test?
Half of the primary outcomes that name the Continuous Performance Test are measured within 8 weeks of the start, and the middle half from 4 weeks to 12 weeks. 25 primary outcomes give a duration.
How many completed depression and bipolar disorder trials that use the Continuous Performance Test have reported results?
15 of the 25 completed studies that name it, 60%, have reported results: 11 posted them on ClinicalTrials.gov, 10 have a results paper linked to the registry record, and 6 did both. The other 10 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
Run the Continuous Performance Test in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.